Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?

Immunity - United States
doi 10.1016/j.immuni.2010.04.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV